CUSIP 03770N101 · who reports it, how much, and how much it matters to them
50 of the 720 hedge fund managers we track reported shares of Apogee Therapeutics Inc (APGE) on Form 13F for 30 June 2026. Between them they reported USD 1.8bn. The largest position belongs to HBK Investments, at USD 378m. The manager with the most riding on it is Slotnik Capital, where it is 8.9% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | HBK Investments7 funds on PPLI.com | USD 378m | 3.7% |
| 2 | Balyasny Asset Management25 funds on PPLI.com | USD 221m | 0.3% |
| 3 | Millennium Management6 funds on PPLI.com | USD 198m | 0.1% |
| 4 | Pentwater Capital Management1 fund on PPLI.com | USD 189m | 1.2% |
| 5 | Perceptive Advisors6 funds on PPLI.com | USD 174m | 2.6% |
| 6 | Whitebox Advisors9 funds on PPLI.com | USD 60m | 0.8% |
| 7 | Magnetar Financial93 funds on PPLI.com | USD 53m | 0.5% |
| 8 | TIG Advisors15 funds on PPLI.com | USD 48m | 2.1% |
| 9 | Cinctive Capital Management5 funds on PPLI.com | USD 46m | 1.7% |
| 10 | Polar Asset Management Partners6 funds on PPLI.com | USD 43m | 0.7% |
| 11 | Fairmount Funds Management2 funds on PPLI.com | USD 40m | 2.6% |
| 12 | Squarepoint Ops7 funds on PPLI.com | USD 39m | 0.0% |
| 13 | Slotnik Capital1 fund on PPLI.com | USD 35m | 8.9% |
| 14 | Adage Capital Management1 fund on PPLI.com | USD 33m | 0.0% |
| 15 | D. E. Shaw & Co.15 funds on PPLI.com | USD 33m | 0.0% |
| 16 | Verition Fund Management3 funds on PPLI.com | USD 21m | 0.1% |
| 17 | Renaissance Technologies13 funds on PPLI.com | USD 19m | 0.0% |
| 18 | Grantham Mayo Van Otterloo & Co1 fund on PPLI.com | USD 18m | 0.0% |
| 19 | Capstone Investment Advisors25 funds on PPLI.com | USD 16m | 0.0% |
| 20 | Twin Securities2 funds on PPLI.com | USD 16m | 7.1% |
| 21 | Melqart Asset Management (UK)3 funds on PPLI.com | USD 16m | 1.5% |
| 22 | Water Island Capital1 fund on PPLI.com | USD 13m | 1.2% |
| 23 | Two Sigma Investments35 funds on PPLI.com | USD 13m | 0.0% |
| 24 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 11m | 1.6% |
| 25 | Marshall Wace LLP84 funds on PPLI.com | USD 10m | 0.0% |
| 26 | Boxer Capital Management1 fund on PPLI.com | USD 9.3m | 0.7% |
| 27 | Prelude Capital Management9 funds on PPLI.com | USD 7.8m | 0.6% |
| 28 | Platinum Investment Management11 funds on PPLI.com | USD 7.7m | 1.9% |
| 29 | Alpine Associates Management9 funds on PPLI.com | USD 7.7m | 0.5% |
| 30 | POINT72 Asset Management17 funds on PPLI.com | USD 7.2m | 0.0% |
| 31 | LMR Partners2 funds on PPLI.com | USD 6.2m | 0.0% |
| 32 | Citadel Advisors32 funds on PPLI.com | USD 5.8m | 0.0% |
| 33 | Tudor Investment Corporation10 funds on PPLI.com | USD 4.7m | 0.0% |
| 34 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 4.1m | 0.0% |
| 35 | Burkehill Global Management5 funds on PPLI.com | USD 4m | 0.1% |
| 36 | Engineers Gate Manager1 fund on PPLI.com | USD 2.8m | 0.0% |
| 37 | Moore Capital Management7 funds on PPLI.com | USD 2.7m | 0.0% |
| 38 | Versor Investments8 funds on PPLI.com | USD 2.4m | 5.1% |
| 39 | Carlson Capital17 funds on PPLI.com | USD 1.9m | 0.4% |
| 40 | Wolverine Asset Management1 fund on PPLI.com | USD 1.4m | 0.0% |
| 41 | Neo Ivy Capital Management1 fund on PPLI.com | USD 1.3m | 0.3% |
| 42 | Nine Masts Capital1 fund on PPLI.com | USD 1.2m | 0.1% |
| 43 | Gamco Asset Management1 fund on PPLI.com | USD 1.1m | 0.0% |
| 44 | Voleon Capital Management13 funds on PPLI.com | USD 630,000 | 0.0% |
| 45 | Bayforest Capital1 fund on PPLI.com | USD 355,000 | 0.3% |
| 46 | CIBC Asset Management69 funds on PPLI.com | USD 230,000 | 0.0% |
| 47 | Walleye Capital8 funds on PPLI.com | USD 220,000 | 0.0% |
| 48 | Exoduspoint Capital Management7 funds on PPLI.com | USD 46,190 | 0.0% |
| 49 | The Quarry1 fund on PPLI.com | USD 21,237 | 0.0% |
| 50 | Freestone Grove Partners1 fund on PPLI.com | USD 133 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Slotnik Capital | USD 35m | 8.9% |
| 2 | Twin Securities | USD 16m | 7.1% |
| 3 | Versor Investments | USD 2.4m | 5.1% |
| 4 | HBK Investments | USD 378m | 3.7% |
| 5 | Fairmount Funds Management | USD 40m | 2.6% |
| 6 | Perceptive Advisors | USD 174m | 2.6% |
| 7 | TIG Advisors | USD 48m | 2.1% |
| 8 | Platinum Investment Management | USD 7.7m | 1.9% |
| 9 | Cinctive Capital Management | USD 46m | 1.7% |
| 10 | Gabelli & Company Investment Advisers | USD 11m | 1.6% |
Apogee Therapeutics Inc trades under the symbol APGE. Its CUSIP, the code used on Form 13F, is 03770N101.
50 of the 720 hedge fund managers PPLI.com tracks reported Apogee Therapeutics Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by HBK Investments (USD 378m), Balyasny Asset Management (USD 221m), Millennium Management (USD 198m), Pentwater Capital Management (USD 189m) and Perceptive Advisors (USD 174m).
50 managers in our coverage reported it, and between them they run 646 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Slotnik Capital, where the position was 8.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Apogee Therapeutics Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.